Saposin C is a frequent target of paraproteins in Gaucher disease‐associated MGUS/multiple myeloma

Patients with Gaucher disease (GD) have an increased risk of monoclonal gammopathies for which antigenic targets might play a role in their pathogenesis. Here we report the identification of saposin C (sapC) as high‐titre (1:1 000 000) target structure of 7/16 GD‐associated paraproteins. Anti‐sapC immunoglobulin (Ig) showed identity with the paraprotein Ig type and subclass in each patient that showed anti‐sapC immunoreactivity. Absorption and depletion studies completely removed the paraprotein from the sera of GD patients. No immunoreactivity against sapC was detected in healthy donors and in other plasma cell dyscrasias, demonstrating that anti‐sapC reactivity is highly restricted to GD. Several uncharacterized forms of post‐translational modified sapC were detected but their role in the pathogenesis is not clear. We confirm the frequent presence of low‐titre (1:250) anti‐lysolipid reactivities in the sera of GD patients but we could show that this immunoreactivity is not mediated by the paraprotein and is not restricted to GD patients.

[1]  M. Dhodapkar,et al.  Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma. , 2016, The New England journal of medicine.

[2]  G. Castaman,et al.  Hematological manifestations and complications of Gaucher disease , 2016, Expert review of hematology.

[3]  M. Pfreundschuh,et al.  Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor. , 2015, The Journal of clinical investigation.

[4]  M. Crescenzi,et al.  Gaucher disease due to saposin C deficiency is an inherited lysosomal disease caused by rapidly degraded mutant proteins. , 2014, Human molecular genetics.

[5]  C. Hollak,et al.  Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature , 2013, British journal of haematology.

[6]  R. Tamargo,et al.  The role of saposin C in Gaucher disease. , 2012, Molecular genetics and metabolism.

[7]  C. Vachon,et al.  Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics. , 2012, Blood.

[8]  M. Pfreundschuh,et al.  Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2A. , 2011, Blood.

[9]  L. Masuelli,et al.  Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting. , 2010, Human molecular genetics.

[10]  M. Pfreundschuh,et al.  Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study. , 2009, The Lancet. Oncology.

[11]  M. Pfreundschuh,et al.  A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS , 2009, International journal of cancer.

[12]  G. Grabowski Phenotype, diagnosis, and treatment of Gaucher's disease , 2008, The Lancet.

[13]  M. Pfreundschuh,et al.  Identification of antigenic targets of paraproteins by expression cloning does not support a causal role of chronic antigenic stimulation in the pathogenesis of multiple myeloma and MGUS , 2007, International journal of cancer.

[14]  P. Meikle,et al.  Saposins A, B, C, and D in plasma of patients with lysosomal storage disorders. , 2000, Clinical chemistry.

[15]  N. Tjandra,et al.  Solution structure of human GAIP (Galpha interacting protein): a regulator of G protein signaling. , 1999, Journal of molecular biology.

[16]  H. Lehrach,et al.  A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library. , 1998, Nucleic acids research.

[17]  B. Maras,et al.  Structural Analysis of Saposin C and B , 1995, The Journal of Biological Chemistry.

[18]  E. Ginns,et al.  Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins). , 1993, Archives of biochemistry and biophysics.

[19]  Y. Kishimoto,et al.  Saposin proteins: structure, function, and role in human lysosomal storage disorders , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  S. Ueno,et al.  Sphingolipid hydrolase activator proteins and their precursors. , 1989, Biochemical and biophysical research communications.